Chronic obstructive pulmonary disease [[electronic resource] /] / [edited by] Robert A. Stockley ... [et al.] |
Pubbl/distr/stampa | Malden, MA ; ; Oxford, : Blackwell Pub., 2007 |
Descrizione fisica | 1 online resource (916 p.) |
Disciplina |
616.2/4
616.24 |
Altri autori (Persone) | StockleyRobert A |
Soggetto topico |
Lungs - Diseases, Obstructive
Lungs - Diseases |
Soggetto genere / forma | Electronic books. |
ISBN |
1-281-32056-0
9786611320560 0-470-75597-0 0-470-75528-8 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Chronic Obstructive Pulmonary Disease; Contents; Contributors; Preface; Section 1: Physiology; 1 Structure-Function Relationships: The Pathophysiology of Airflow Obstruction; 2 The Physiology of Breathlessness; 3 The Physiology of Muscle; 4 Exercise Limitations and Cardiopulmonary Exercise Testing in Copd; 5 Clinical Assessment of Control of Breathing; 6 Physiology and Pathobiology of the Lung Circulation; 7 Sleep In Patients With Copd; 8 The Physiology of Cough; 9 The Physiology of Gas Exchange; Section 2: COPD and allied conditions; 10 The Natural History of Copd; 11 Cystic Fibrosis
12 Bronchiectasis and Copd13 Obliterative Bronchiolitis; 14 Asthma; 15 Copd: Clinical Presentation and Evaluation; 16 Monitoring and Outcomes; Section 3: Host Defences and Inflammation; 17 Mucociliary Clearance; 18 Mucosal Immunity; 19 Copd and Pulmonary Surfactant; 20 The Macrophage and Its Role in the Pathogenesis of Copd; 21 Eosinophils and Copd; 22 Airway Epithelial Defence, Repair and Regeneration; 23 The Role of The Neutrophil In The Pathogenesis of Copd; 24 Lymphocytes; 25 Cytokines; 26 Leukotrienes In Copd: The Unexploited Potential 27 Cigarette Smoking, Emphysema and Lung Endothelium28 Mesenchymal Cells of the Lung; Section 4: Pathogenesis; 29 Lung Development; 30 Animal Models; 31 Proteinases and Copd; Colour Plate Section Falls Between Pp. 354 and 355; 32 Oxidants; 33 Cigarette Smoke-Induced Disease; 34 Copd and Air Pollution; 35 Viruses in Copd; 36 Bacteria; 37 Genetic Factors; 38 α1-Antitrypsin Deficiency; 39 Body Weight and Systemic Effects; 40 Lung Connective Tissue; Section 5: Clinical Considerations and Complications; 41 Aerosols and Delivery Systems; 42 Gastro-Oesophageal Reflux; 43 Upper Airway Diseases 44 Acute Pulmonary Embolism45 Copd and Lung Cancer; 46 Infection Management and Airflow Obstruction; 47 Mechanical Ventilation For Exacerbation of Copd; 48 Comorbidity; Section 6: Current and Future Treatment; 49 Primary Care; 50 Pulmonary Rehabilitation; 51 Social Support; 52 Long-Term Invasive Mechanical Ventilation; 53 Smoking Cessation; 54 Oxygen Therapy in Copd; 55 Surgical Therapy For Copd; 56 Anticholinergics in Copd; 57 β2-Agonists; 58 Corticosteroids; 59 Phosphodiesterase 4 Inhibitors In The Treatment of Copd; 60 Antibiotic Therapy in Patients With Copd; 61 Antioxidants 62 Mucolytics For Copd63 End-of-Life and Palliative Care for Patients With Copd; 64 Economic Burden of Copd; 65 Pharmacoepidemiology of Copd; 66 Social and Behavioural Impact of Copd ... Research Opportunities; 67 Guidelines; Section 7: Pharmacotherapy: Developing Therapies; 68 Protease Inhibitors; 69 Retinoids; 70 Chemokines in Copd; Index |
Record Nr. | UNINA-9910145414603321 |
Malden, MA ; ; Oxford, : Blackwell Pub., 2007 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Chronic obstructive pulmonary disease [[electronic resource] /] / [edited by] Robert A. Stockley ... [et al.] |
Pubbl/distr/stampa | Malden, MA ; ; Oxford, : Blackwell Pub., 2007 |
Descrizione fisica | 1 online resource (916 p.) |
Disciplina |
616.2/4
616.24 |
Altri autori (Persone) | StockleyRobert A |
Soggetto topico |
Lungs - Diseases, Obstructive
Lungs - Diseases |
ISBN |
1-281-32056-0
9786611320560 0-470-75597-0 0-470-75528-8 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Chronic Obstructive Pulmonary Disease; Contents; Contributors; Preface; Section 1: Physiology; 1 Structure-Function Relationships: The Pathophysiology of Airflow Obstruction; 2 The Physiology of Breathlessness; 3 The Physiology of Muscle; 4 Exercise Limitations and Cardiopulmonary Exercise Testing in Copd; 5 Clinical Assessment of Control of Breathing; 6 Physiology and Pathobiology of the Lung Circulation; 7 Sleep In Patients With Copd; 8 The Physiology of Cough; 9 The Physiology of Gas Exchange; Section 2: COPD and allied conditions; 10 The Natural History of Copd; 11 Cystic Fibrosis
12 Bronchiectasis and Copd13 Obliterative Bronchiolitis; 14 Asthma; 15 Copd: Clinical Presentation and Evaluation; 16 Monitoring and Outcomes; Section 3: Host Defences and Inflammation; 17 Mucociliary Clearance; 18 Mucosal Immunity; 19 Copd and Pulmonary Surfactant; 20 The Macrophage and Its Role in the Pathogenesis of Copd; 21 Eosinophils and Copd; 22 Airway Epithelial Defence, Repair and Regeneration; 23 The Role of The Neutrophil In The Pathogenesis of Copd; 24 Lymphocytes; 25 Cytokines; 26 Leukotrienes In Copd: The Unexploited Potential 27 Cigarette Smoking, Emphysema and Lung Endothelium28 Mesenchymal Cells of the Lung; Section 4: Pathogenesis; 29 Lung Development; 30 Animal Models; 31 Proteinases and Copd; Colour Plate Section Falls Between Pp. 354 and 355; 32 Oxidants; 33 Cigarette Smoke-Induced Disease; 34 Copd and Air Pollution; 35 Viruses in Copd; 36 Bacteria; 37 Genetic Factors; 38 α1-Antitrypsin Deficiency; 39 Body Weight and Systemic Effects; 40 Lung Connective Tissue; Section 5: Clinical Considerations and Complications; 41 Aerosols and Delivery Systems; 42 Gastro-Oesophageal Reflux; 43 Upper Airway Diseases 44 Acute Pulmonary Embolism45 Copd and Lung Cancer; 46 Infection Management and Airflow Obstruction; 47 Mechanical Ventilation For Exacerbation of Copd; 48 Comorbidity; Section 6: Current and Future Treatment; 49 Primary Care; 50 Pulmonary Rehabilitation; 51 Social Support; 52 Long-Term Invasive Mechanical Ventilation; 53 Smoking Cessation; 54 Oxygen Therapy in Copd; 55 Surgical Therapy For Copd; 56 Anticholinergics in Copd; 57 β2-Agonists; 58 Corticosteroids; 59 Phosphodiesterase 4 Inhibitors In The Treatment of Copd; 60 Antibiotic Therapy in Patients With Copd; 61 Antioxidants 62 Mucolytics For Copd63 End-of-Life and Palliative Care for Patients With Copd; 64 Economic Burden of Copd; 65 Pharmacoepidemiology of Copd; 66 Social and Behavioural Impact of Copd ... Research Opportunities; 67 Guidelines; Section 7: Pharmacotherapy: Developing Therapies; 68 Protease Inhibitors; 69 Retinoids; 70 Chemokines in Copd; Index |
Record Nr. | UNISA-996203974503316 |
Malden, MA ; ; Oxford, : Blackwell Pub., 2007 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. di Salerno | ||
|
Chronic obstructive pulmonary disease [[electronic resource] /] / [edited by] Robert A. Stockley ... [et al.] |
Pubbl/distr/stampa | Malden, MA ; ; Oxford, : Blackwell Pub., 2007 |
Descrizione fisica | 1 online resource (916 p.) |
Disciplina |
616.2/4
616.24 |
Altri autori (Persone) | StockleyRobert A |
Soggetto topico |
Lungs - Diseases, Obstructive
Lungs - Diseases |
ISBN |
1-281-32056-0
9786611320560 0-470-75597-0 0-470-75528-8 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Chronic Obstructive Pulmonary Disease; Contents; Contributors; Preface; Section 1: Physiology; 1 Structure-Function Relationships: The Pathophysiology of Airflow Obstruction; 2 The Physiology of Breathlessness; 3 The Physiology of Muscle; 4 Exercise Limitations and Cardiopulmonary Exercise Testing in Copd; 5 Clinical Assessment of Control of Breathing; 6 Physiology and Pathobiology of the Lung Circulation; 7 Sleep In Patients With Copd; 8 The Physiology of Cough; 9 The Physiology of Gas Exchange; Section 2: COPD and allied conditions; 10 The Natural History of Copd; 11 Cystic Fibrosis
12 Bronchiectasis and Copd13 Obliterative Bronchiolitis; 14 Asthma; 15 Copd: Clinical Presentation and Evaluation; 16 Monitoring and Outcomes; Section 3: Host Defences and Inflammation; 17 Mucociliary Clearance; 18 Mucosal Immunity; 19 Copd and Pulmonary Surfactant; 20 The Macrophage and Its Role in the Pathogenesis of Copd; 21 Eosinophils and Copd; 22 Airway Epithelial Defence, Repair and Regeneration; 23 The Role of The Neutrophil In The Pathogenesis of Copd; 24 Lymphocytes; 25 Cytokines; 26 Leukotrienes In Copd: The Unexploited Potential 27 Cigarette Smoking, Emphysema and Lung Endothelium28 Mesenchymal Cells of the Lung; Section 4: Pathogenesis; 29 Lung Development; 30 Animal Models; 31 Proteinases and Copd; Colour Plate Section Falls Between Pp. 354 and 355; 32 Oxidants; 33 Cigarette Smoke-Induced Disease; 34 Copd and Air Pollution; 35 Viruses in Copd; 36 Bacteria; 37 Genetic Factors; 38 α1-Antitrypsin Deficiency; 39 Body Weight and Systemic Effects; 40 Lung Connective Tissue; Section 5: Clinical Considerations and Complications; 41 Aerosols and Delivery Systems; 42 Gastro-Oesophageal Reflux; 43 Upper Airway Diseases 44 Acute Pulmonary Embolism45 Copd and Lung Cancer; 46 Infection Management and Airflow Obstruction; 47 Mechanical Ventilation For Exacerbation of Copd; 48 Comorbidity; Section 6: Current and Future Treatment; 49 Primary Care; 50 Pulmonary Rehabilitation; 51 Social Support; 52 Long-Term Invasive Mechanical Ventilation; 53 Smoking Cessation; 54 Oxygen Therapy in Copd; 55 Surgical Therapy For Copd; 56 Anticholinergics in Copd; 57 β2-Agonists; 58 Corticosteroids; 59 Phosphodiesterase 4 Inhibitors In The Treatment of Copd; 60 Antibiotic Therapy in Patients With Copd; 61 Antioxidants 62 Mucolytics For Copd63 End-of-Life and Palliative Care for Patients With Copd; 64 Economic Burden of Copd; 65 Pharmacoepidemiology of Copd; 66 Social and Behavioural Impact of Copd ... Research Opportunities; 67 Guidelines; Section 7: Pharmacotherapy: Developing Therapies; 68 Protease Inhibitors; 69 Retinoids; 70 Chemokines in Copd; Index |
Record Nr. | UNINA-9910830454603321 |
Malden, MA ; ; Oxford, : Blackwell Pub., 2007 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Chronic obstructive pulmonary disease / / [edited by] Robert A. Stockley ... [et al.] |
Pubbl/distr/stampa | Malden, MA ; ; Oxford, : Blackwell Pub., 2007 |
Descrizione fisica | 1 online resource (916 p.) |
Disciplina |
616.2/4
616.24 |
Altri autori (Persone) | StockleyRobert A |
Soggetto topico |
Lungs - Diseases, Obstructive
Lungs - Diseases |
ISBN |
1-281-32056-0
9786611320560 0-470-75597-0 0-470-75528-8 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Chronic Obstructive Pulmonary Disease; Contents; Contributors; Preface; Section 1: Physiology; 1 Structure-Function Relationships: The Pathophysiology of Airflow Obstruction; 2 The Physiology of Breathlessness; 3 The Physiology of Muscle; 4 Exercise Limitations and Cardiopulmonary Exercise Testing in Copd; 5 Clinical Assessment of Control of Breathing; 6 Physiology and Pathobiology of the Lung Circulation; 7 Sleep In Patients With Copd; 8 The Physiology of Cough; 9 The Physiology of Gas Exchange; Section 2: COPD and allied conditions; 10 The Natural History of Copd; 11 Cystic Fibrosis
12 Bronchiectasis and Copd13 Obliterative Bronchiolitis; 14 Asthma; 15 Copd: Clinical Presentation and Evaluation; 16 Monitoring and Outcomes; Section 3: Host Defences and Inflammation; 17 Mucociliary Clearance; 18 Mucosal Immunity; 19 Copd and Pulmonary Surfactant; 20 The Macrophage and Its Role in the Pathogenesis of Copd; 21 Eosinophils and Copd; 22 Airway Epithelial Defence, Repair and Regeneration; 23 The Role of The Neutrophil In The Pathogenesis of Copd; 24 Lymphocytes; 25 Cytokines; 26 Leukotrienes In Copd: The Unexploited Potential 27 Cigarette Smoking, Emphysema and Lung Endothelium28 Mesenchymal Cells of the Lung; Section 4: Pathogenesis; 29 Lung Development; 30 Animal Models; 31 Proteinases and Copd; Colour Plate Section Falls Between Pp. 354 and 355; 32 Oxidants; 33 Cigarette Smoke-Induced Disease; 34 Copd and Air Pollution; 35 Viruses in Copd; 36 Bacteria; 37 Genetic Factors; 38 α1-Antitrypsin Deficiency; 39 Body Weight and Systemic Effects; 40 Lung Connective Tissue; Section 5: Clinical Considerations and Complications; 41 Aerosols and Delivery Systems; 42 Gastro-Oesophageal Reflux; 43 Upper Airway Diseases 44 Acute Pulmonary Embolism45 Copd and Lung Cancer; 46 Infection Management and Airflow Obstruction; 47 Mechanical Ventilation For Exacerbation of Copd; 48 Comorbidity; Section 6: Current and Future Treatment; 49 Primary Care; 50 Pulmonary Rehabilitation; 51 Social Support; 52 Long-Term Invasive Mechanical Ventilation; 53 Smoking Cessation; 54 Oxygen Therapy in Copd; 55 Surgical Therapy For Copd; 56 Anticholinergics in Copd; 57 β2-Agonists; 58 Corticosteroids; 59 Phosphodiesterase 4 Inhibitors In The Treatment of Copd; 60 Antibiotic Therapy in Patients With Copd; 61 Antioxidants 62 Mucolytics For Copd63 End-of-Life and Palliative Care for Patients With Copd; 64 Economic Burden of Copd; 65 Pharmacoepidemiology of Copd; 66 Social and Behavioural Impact of Copd ... Research Opportunities; 67 Guidelines; Section 7: Pharmacotherapy: Developing Therapies; 68 Protease Inhibitors; 69 Retinoids; 70 Chemokines in Copd; Index |
Record Nr. | UNINA-9910877063403321 |
Malden, MA ; ; Oxford, : Blackwell Pub., 2007 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|